Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alzheimer's activists to demonstrate at FDA

Executive Summary

Volunteers representing Alzheimer's patients will hold a demonstration Sept. 24 at FDA's 200 C St. building, near the U.S. Capitol, to urge FDA to approve quickly anti-dementia drugs such as Warner-Lambert's Cognex (tacrine). The demonstration is being organized by William Summers, MD, who in 1986 reported the first clinical results with tacrine in a letter to the New England Journal of Medicine. FDA later concluded that the study was seriously flawed. Summers will present petitions demanding immediate action on Cognex and/or a congressional hearing on delays in the drug's approval.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021361

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel